Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 44 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

9%

4 trials in Phase 3/4

Results Transparency

4%

1 of 25 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

29Total
Not Applicable (21)
P 2 (4)
P 3 (2)
P 4 (2)

Trial Status

Completed25
Recruiting8
Unknown5
Not Yet Recruiting4
Withdrawn2

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 25 completed trials

Clinical Trials (44)

Showing 20 of 20 trials
NCT05462938Not ApplicableCompleted

Conscious Sedation for Transcatheter Aortic Valve Implantation

NCT07542912Not ApplicableNot Yet Recruiting

Sintilimab, Chidamide, and Azacitidine for Untreated Stage I-II Extranodal NK/T-Cell Lymphoma

NCT05282654Not ApplicableRecruiting

Real-time Symptom Monitoring Using ePROs to Prevent Adverse Events During Care Transitions

NCT06433414Not ApplicableNot Yet Recruiting

PAUSE: Sick Day Medication Management Mobile App Study

NCT07302477Not ApplicableCompleted

Human Milk Oligosaccharides (HMOs) - Post Marketing Study on Infants (NeHMO)

NCT03436381Completed

Can Sleep Apnea Screening Questionnaire Predict Adverse Events in Endoscopic Studies

NCT04763876Phase 4Completed

Intramuscular Ketorolac at Two Single-Dose Regimens

NCT05862103Recruiting

Long-Term Follow-Up in Patients With Acute Myocardial Infarction Cohort

NCT07098351Not ApplicableRecruitingPrimary

Efficacy and Safety of Nalfurafine Hydrochloride ODT for Moderate-to-Severe Pruritus in Patients on Peritoneal Dialysis

NCT06915389Recruiting

Metabolomic and Lipidomic Analysis Predicts Immunotherapy-related Adverse Events in Gastric Cancer Patients

NCT05369962Completed

Adverse Event Prediction in Geriatric Patients in the ED With Ultrasound

NCT03264352Phase 4Recruiting

Intervention for High-normal Blood Pressure in Adults With Type 2 Diabetes

NCT04716075Phase 2Completed

Acalabrutinib in CLL and MCL Patients Subjected to Allogeneic Hematopoietic Stem Cell Transplantation (alloSCT)

NCT06693440Recruiting

The Immune Assessment of PD-1 Antibody Therapy in Tumor

NCT04018898Completed

Older Emergency Department Users and Short-term Adverse Events at the Index Visit

NCT06174844Recruiting

Assessment of the Humanisation of Care in Hospitals in Andalusia-Spain

NCT05818826Phase 2Recruiting

Early Versus Conventional Cessation of Hydrocortisone in Septic Shock

NCT05321160Not ApplicableCompletedPrimary

Comparison of the Sedation Effect of Esketamine and Sevoflurane for Pediatric Ophthalmological Procedure

NCT05557981Not ApplicableCompleted

The Impact of a Novel Coaching Program on Medical Errors and Well-Being of Physicians

NCT06230341Not ApplicableNot Yet RecruitingPrimary

Patient Safety Incidents in Coordinated Primary Care Teams: a Multi-method Study

Scroll to load more

Research Network

Activity Timeline